Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era
- PMID: 19064681
- PMCID: PMC2706113
- DOI: 10.1161/CIRCULATIONAHA.108.789446
Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era
Abstract
Background: There is wide geographic variation in the use of coronary revascularization in the United States. Rates are closely related to rates of coronary angiography. We assessed the relationship between coronary angiography and coronary artery revascularization by procedure type (coronary artery bypass graft surgery or percutaneous coronary intervention).
Methods and results: Using Part B claims for a 20% sample of the Medicare population, we calculated population-based rates of testing and treatment by region, using events identified in Part B claims as the numerator and the total number of Medicare beneficiaries residing in the area as the denominator and adjusting for regional differences in demographic characteristics with the indirect method. Cardiac catheterization rates varied substantially across regions, from 16 to 77 per 1000 Medicare beneficiaries. The relationship between coronary angiography rates and total coronary revascularization rates was strong (R(2)=0.84). However, there was only a modest association between coronary angiography rates and coronary artery bypass graft surgery rates (R(2)=0.41) with the suggestion of a threshold effect. The association between coronary angiography rates and percutaneous coronary intervention rates was strong (R(2)=0.78) and linear.
Conclusions: The diagnostic-therapeutic cascade for coronary artery disease differs by therapeutic intervention. For coronary artery bypass graft surgery, the relationship is modest, and there appears to be a testing threshold beyond which additional tests do not result in additional surgeries. For percutaneous coronary intervention, the relationship is very tight, and no threshold appears to exist. Given the results of recent studies of medical versus invasive management of stable coronary disease, patients living in high-diagnostic-intensity regions may be getting more treatment than they want or need.
Figures
Similar articles
-
Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease.Am J Cardiol. 2012 Nov 1;110(9):1270-4. doi: 10.1016/j.amjcard.2012.06.029. Epub 2012 Jul 21. Am J Cardiol. 2012. PMID: 22819426 Free PMC article.
-
Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes.Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):193-7. doi: 10.1161/CIRCOUTCOMES.110.958744. Epub 2011 Feb 8. Circ Cardiovasc Qual Outcomes. 2011. PMID: 21304092 Free PMC article.
-
One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.J Am Coll Cardiol. 2013 Jun 25;61(25):2525-33. doi: 10.1016/j.jacc.2013.04.007. Epub 2013 Apr 23. J Am Coll Cardiol. 2013. PMID: 23623906
-
Integrated coronary revascularization.J Invasive Cardiol. 1999 Mar;11(3):184-90; discussion 190-1. J Invasive Cardiol. 1999. PMID: 10745509 Review. No abstract available.
-
Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.Tex Heart Inst J. 1995;22(2):145-61. Tex Heart Inst J. 1995. PMID: 7647598 Free PMC article. Review.
Cited by
-
Assessment of atherosclerotic plaque burden: comparison of AI-QCT versus SIS, CAC, visual and CAD-RADS stenosis categories.Int J Cardiovasc Imaging. 2024 Jun;40(6):1201-1209. doi: 10.1007/s10554-024-03087-x. Epub 2024 Apr 17. Int J Cardiovasc Imaging. 2024. PMID: 38630211 Free PMC article.
-
Atherosclerosis Imaging Quantitative Computed Tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial.Clin Cardiol. 2023 May;46(5):477-483. doi: 10.1002/clc.23995. Epub 2023 Feb 27. Clin Cardiol. 2023. PMID: 36847047 Free PMC article.
-
The Merits, Limitations, and Future Directions of Cost-Effectiveness Analysis in Cardiac MRI with a Focus on Coronary Artery Disease: A Literature Review.J Cardiovasc Dev Dis. 2022 Oct 17;9(10):357. doi: 10.3390/jcdd9100357. J Cardiovasc Dev Dis. 2022. PMID: 36286309 Free PMC article. Review.
-
Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan.BMJ Open. 2022 Aug 30;12(8):e061617. doi: 10.1136/bmjopen-2022-061617. BMJ Open. 2022. PMID: 36041769 Free PMC article.
-
Cardiac computed tomographic angiography after abnormal ischemia test as a gatekeeper to invasive coronary angiography.Int J Cardiovasc Imaging. 2022 Apr;38(4):883-893. doi: 10.1007/s10554-021-02426-6. Epub 2022 Feb 28. Int J Cardiovasc Imaging. 2022. PMID: 35226221
References
-
- Wennberg DE, Kellett MA, Dickens JD, Jr, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA. 1996;275:1161–4. - PubMed
-
- Wennberg DE, Birkmeyer JD, Birkmeyer NJO, Lucas FL, Malenka DJ, McGrath PD, Lurie JD, O’Connor GT, Quinton HB, Shawver TA, Siewers AE. The Dartmouth Atlas of Cardiovascular Health Care. AHA Press; Chicago: 1999.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
